Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens.

Front Neurol · 2025 · PMC12714632 · PMID 41426979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not as significantno p-value reported

Although its inhibitory effect on IL-6, IL-17, TNF- α , and IFN-α is not as significant as that of glucocorticoids and B-cell depletion agents, tacrolimus maintains immune tolerance by reducing the production of cytokines and activation of immune cells.

also in 271 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.